Beo Therapeutics ApS: Financial statements 2020
CVR: 39880377
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Beo Therapeutics ApS (CVR 39880377) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 0. Equity in the 2020 report amounted to DKK 67,429. The solvency ratio was 100%.
- Profit/Loss
- DKK 0
- Equity
- DKK 67,429
- Total Assets
- DKK 67,429
Official annual report
How creditworthy is Beo Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Beo Therapeutics ApS has published its interim report for the period September 26, 2018 – December 31, 2019.
About Beo Therapeutics ApS
Beo Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Beo Therapeutics IVS. The management consists of Rikke Christina Nielsen. The company is owned by Rikke Christina Nielsen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 4,985 compared with DKK -4,910 the year before. Equity in the 2025 report amounted to DKK 40,075.